Why the study?
Do antiplatelet agents reduce the incidence of symptomatic venous thromboembolism in patients undergoing hip fracture surgery?
Population
824 consecutive patients undergoing 858 hip fracture surgeries at an East Asian institute between May 2003…
Comparison
Antiplatelet agents (users, n=250 surgeries) vs Non-users of antiplatelet agents (n=608 surgeries)
Design
Cohort
Authors
Loading...
Antiplatelet agents were not associated with lower symptomatic VTE after hip fracture surgery; hypothesis-generating and should not yet change practice.
Do antiplatelet agents reduce the incidence of symptomatic venous thromboembolism in patients undergoing hip fracture surgery?
Antiplatelet agents do not significantly reduce the risk of symptomatic venous thromboembolism following hip fracture surgery.
Ji et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: